Source: Υπουργείο Υγείας (CY) Revision Year: 2018 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Alutril Forte 500 mg/250 mg chewable tablets.
| Pharmaceutical Form |
|---|
|
Chewable tablet. White, round, flat, scored, flavoured chewable tablets. The score line is not intended for breaking the tablet. |
Each chewable tablet contains 500 mg magnesium trisilicate and 250 mg hydrated aluminium oxide.
Excipient(s) with known effect: This product contains 100 mg sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Aluminium hydroxide |
Aluminium hydroxide is a slow-acting antacid. It is used to provide symptomatic relief in gastric hyperacidity. In addition, the antipeptic and demulcent activity of aluminium hydroxide helps to protect inflamed gastric mucosa against further irritation by gastric secretions. |
|
| Magnesium silicate |
|
| List of Excipients |
|---|
|
Mannitol |
PVC/Aluminium blisters. Pack-sizes of 10, 50 and 500 chewable tablets.
PP containers with PE closure. Pack-size of 500 chewable tablets.
Not all pack-sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
19914
Date of first authorization: 23 December 2005
Date of latest renewal: 17 March 2011
| Drug | Countries | |
|---|---|---|
| ALUTRIL FORTE | Cyprus, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
